Primary Record
e-64
- In stock
- 7,738 g
- Purity
- 99.6 %
- CAS
- 66701-25-5
Compound Identifiers & Properties
- CAS
- 66701-25-5
- PubChem CID
- 123985
- SMILES
- CC(C)C[C@@H](C(=O)NCCCCN=C(N)N)NC(=O)[C@@H]1[C@H](O1)C(=O)O
- Canonical SMILES
- CC(C)C[C@H](NC(=O)[C@H]1O[C@@H]1C(=O)O)C(=O)NCCCCN=C(N)N
Names & Synonyms
- e-64
- 66701-25-5
- Proteinase inhibitor E 64
- Thiol protease inhibitor
- 6,8-Diprenylorobol
- E 64 (proteinase inhibitor)
- AC1L3XOG
- RefChem:898897
- GlyTouCan:G57990VJ
- Proteinase inhibitor E64
- UNII-R76F7856MV
- AC1Q5JQ8
- CHEMBL374508
- C15H27N5O5
- R76F7856MV
- E 64
- MFCD00080261
- SCHEMBL4740187
- SCHEMBL29440579
- CHEBI:30270
- CTK8C4337
- BRN 1405664
- DTXSID90985271
- PROTEINASE INHIBITOR E-64
- DTXCID501412467
- GLXC-07974
- KST-1A7499
- EX-A2284
- G57990VJ
- IES-4096
- ANW-71599
- AR-1A3459
- BDBM50157741
- CID123985
- MFCD07366493
- MFCD13184333
- ZINC13493525
- AKOS016007415
- C15-H27-N5-O5
- BAT-015060
- CCG-207844
- CCG-208198
- CS-4140
- FD21944
- FE29621
- RTR-022531
- L-trans-Epoxysuccinyl-Leu-4-guanidinobutylamide
- NCGC00163544-01
- NCGC00163544-09
- (2S,3S)-3-(((S)-1-((4-Guanidinobutyl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)oxirane-2-carboxylic acid
- AC-36011
- AN-38452
- DA-52771
- HY-15282
- SC-98492
- SY076761
- LS-100998
- E-64, 98% - 10MG 10mg
- FT-0625639
- 5-18-07-00006 (Beilstein Handbook Reference)
- A13257
- C01341
- H51107
- trans-Epoxysuccinyl-L-leucylamido(4-guanidino)butane
- E64
- trans-epoxysuccinyl-l-leucylamido-(4-guanidino)butane
- A903528
- L-trans-epoxysuccinyl-leucylamido(4-guanidino)butane
- Q5321373
- (L-3-trans-Carboxyoxiran-2-carbonyl)-L-leucyl-admat
- (2S,3S)-3-[[(2S)-1-[4-(diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid
- (L-3-TRANS-CARBOXYOXIRANE-2-CARBONYL)-L-LEUCYLAGMATINE HEMIHYDRATE
- (L-3-TRANS-CARBOXYOXIRANE-2-CARBONYL)-L-LEUCYLAGMA
- (2s,3s)-3-({(2s)-1-[(4-carbamimidamidobutyl)amino]-4-methyl-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylic acid
- (2S,3S)-3-[[(1S)-1-(4-guanidinobutylcarbamoyl)-3-methyl-butyl]carbamoyl]oxirane-2-carboxylic acid
- N-(N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl)agmatine
- N-[N-(L-3-trans-carboxyirane-2-carbonyl)-L-leucyl]-agmatine
- 3-[[[(1S)-1-[[[4-[(aminoiminomethyl)amino]butyl]amino]carbonyl]-3-methylbutyl]amino]carbonyl]-(2S,3S)-oxiranecarboxylic acid
- 68140-58-9
- Oxiranecarboxylic acid, 3-(((1-(((4-((aminoiminomethyl)amino)butyl)amino)carbonyl)-3-methylbutyl)amino)carbonyl)-, (2S-(2-alpha,3-beta(R*)))-
- Oxiranecarboxylic acid, 3-(((1-(((4-((aminoiminomethyl)amino)butyl)amino)carbonyl)-3-methylbutyl)amino)carbonyl)-, (2S-(2alpha,3beta(R*)))-
- [1-[N-[(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl]amino]-4-guanidinobutane]
- 3-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis(3-methylbut-2-enyl)chromen-4-one
- (2S,3S)-3-(((S)-1-((4-Guanidinobutyl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)oxirane-2-carboxylic
- (2S,3S)-3-((S)-1-(4-Guanidinobutylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)oxirane-2-carboxylic acid
- (2S,3S)-3-(N-{(S)-1-[N-(4-guanidinobutyl)carbamoyl]3-methylbutyl}carbamoyl)oxirane-2-carboxylic acid
- (2S,3S)-3-[[(S)-1-[(4-Guanidinobutyl)amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic Acid
- (2S,3S)-3-[[[(1S)-1-[[[4-(Aminoiminomethyl)amino]butyl]amino]carbonyl]-3-methylbutyl]amino]carbonyl]-2-oxiranecarboxylic acid
- (2S,3S)-3-{[(1S)-1-[(4-CARBAMIMIDAMIDOBUTYL)CARBAMOYL]-3-METHYLBUTYL]CARBAMOYL}OXIRANE-2-CARBOXYLIC ACID
- 2-OXIRANECARBOXYLIC ACID, 3-((((1S)-1-(((4-((AMINOIMINOMETHYL)AMINO)BUTYL)AMINO)CARBONYL)-3-METHYLBUTYL)AMINO)CARBONYL)-, (2S,3S)-
- 2-Oxiranecarboxylic acid, 3-[[[(1S)-1-[[[4-[(aminoiminomethyl)amino]butyl]amino]carbonyl]-3-methylbutyl]amino]carbonyl]-, (2S,3S)-
- 3-[[1-[4-(diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid
- 66777-70-6
- 80408-29-3